Compare Alcon AG (ALC) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs First Citizens BancShares Inc — how do they compare? Alcon AG trades at $73.49 (market cap $35.29B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: Alcon AG is the larger of the two by market cap, and Alcon AG pays the higher dividend (0.49%). Which is the better fit depends on your goals.
| ALC | FCNCA | |
|---|---|---|
Market Cap | $35.29B | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $90.12 | $2.27K |
52-Week Low | $62.02 | $1.64K |
Enterprise Value | $39.13B | — |
Dividend Yield | 0.49% | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $73.52, down 2.43% on the day, with a bullish technical signal from moving averages. Recent Q2 2026 earnings beat estimates, and the company raised its 2026 profitability outlook. Revenue growth is steady, reaching $10.40B in 2025, though net income margin dipped to 5.92%. The stock is supported by strong analyst consensus, with a price target of $85.85.
Outlook is positive due to earnings beats and raised guidance, but high P/E of 56.17 poses valuation risk. Competition and margin pressures are key concerns. Institutional interest is rising, with Bill Ackman's new position noted in August 2026 news.
First Citizens BancShares (FCNCA) trades at $2,271.31, up 0.81% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with a 12.19 P/E ratio, 25.23% net income margin, and consistent earnings beats in recent quarters. Recent business developments include expansion of commercial lending operations and strategic real estate acquisitions, supporting growth initiatives.
FCNCA presents a mixed outlook with strong earnings performance and reasonable valuation offset by cautious analyst sentiment. While technical indicators suggest continued upside potential, the 81.82% hold rating from analysts indicates concerns about valuation and deposit risks. Key opportunities include expanding commercial banking services, while risks center on net interest margin pressure and elevated uninsured deposits at 38.3%.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
